{"id":"https://openalex.org/W1938215938","doi":"https://doi.org/10.1002/ijc.29083","title":"An Fc\u2010optimized NKG2D\u2010immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia","display_name":"An Fc\u2010optimized NKG2D\u2010immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia","publication_year":2014,"publication_date":"2014-07-21","ids":{"openalex":"https://openalex.org/W1938215938","doi":"https://doi.org/10.1002/ijc.29083","mag":"1938215938","pmid":"https://pubmed.ncbi.nlm.nih.gov/25046567"},"language":"en","primary_location":{"id":"doi:10.1002/ijc.29083","doi":"https://doi.org/10.1002/ijc.29083","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ijc.29083","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1002/ijc.29083","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088173839","display_name":"Julia Steinbacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Steinbacher","raw_affiliation_strings":["Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018090063","display_name":"Katrin Baltz\u2010Ghahremanpour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katrin Baltz\u2010Ghahremanpour","raw_affiliation_strings":["Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071199486","display_name":"Benjamin Joachim Schmiedel","orcid":"https://orcid.org/0000-0002-9103-9378","observed_orcids":["https://orcid.org/0000-0002-9103-9378"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Benjamin Joachim Schmiedel","raw_affiliation_strings":["Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004327073","display_name":"Alexander Steinle","orcid":"https://orcid.org/0000-0001-5081-8503","observed_orcids":["https://orcid.org/0000-0001-5081-8503"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexander Steinle","raw_affiliation_strings":["Institute for Molecular Medicine, Goethe University, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Medicine, Goethe University, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066615137","display_name":"Gundram Jung","orcid":"https://orcid.org/0000-0002-2831-2829","observed_orcids":["https://orcid.org/0000-0002-2831-2829"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I4391767962","display_name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung","ror":"https://ror.org/02pqn3g31","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4391767962","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gundram Jung","raw_affiliation_strings":["Department of Immunology, Eberhard Karls University, Tuebingen, Germany","German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529","https://openalex.org/I4391767962"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046423498","display_name":"Ayline K\u00fcbler","orcid":"https://orcid.org/0009-0007-9717-5569","observed_orcids":["https://orcid.org/0009-0007-9717-5569"]},"institutions":[{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ayline K\u00fcbler","raw_affiliation_strings":["Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021680815","display_name":"Maya Caroline Andre","orcid":"https://orcid.org/0000-0003-1555-2011","observed_orcids":["https://orcid.org/0000-0003-1555-2011"]},"institutions":[{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]},{"id":"https://openalex.org/I4210126115","display_name":"University Children\u2019s Hospital Basel","ror":"https://ror.org/02nhqek82","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210126115"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["CH","DE"],"is_corresponding":false,"raw_author_name":"Maya Caroline Andr\u00e9","raw_affiliation_strings":["Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany","Department of Pediatric Intensive Care, University Children's Hospital, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796","https://openalex.org/I8087733"]},{"raw_affiliation_string":"Department of Pediatric Intensive Care, University Children's Hospital, Basel, Switzerland","institution_ids":["https://openalex.org/I4210126115"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002838487","display_name":"Ludger Gro\u00dfe\u2010Hovest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ludger Grosse\u2010Hovest","raw_affiliation_strings":["Department of Immunology, Eberhard Karls University, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026255080","display_name":"Helmut Rainer Salih","orcid":"https://orcid.org/0000-0002-6719-1847","observed_orcids":["https://orcid.org/0000-0002-6719-1847"]},"institutions":[{"id":"https://openalex.org/I4391767962","display_name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung","ror":"https://ror.org/02pqn3g31","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4391767962","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Helmut Rainer Salih","raw_affiliation_strings":["Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Heidelberg, Germany","Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Heidelberg, Germany","institution_ids":["https://openalex.org/I4391767962"]},{"raw_affiliation_string":"Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5026255080"],"corresponding_institution_ids":["https://openalex.org/I4391767962","https://openalex.org/I8087733"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":{"value":5030,"currency":"USD","value_usd":5030},"fwci":1.2692,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.77277475,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"136","issue":"5","first_page":"1073","last_page":"1084"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.9610000252723694},{"id":"https://openalex.org/keywords/nkg2d-ligands","display_name":"NKG2D ligands","score":0.75},{"id":"https://openalex.org/keywords/fc-engineering","display_name":"Fc engineering","score":0.6389999985694885},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9890000224113464},{"id":"https://openalex.org/keywords/leukemia-immunotherapy","display_name":"leukemia immunotherapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/rituximab-combination","display_name":"rituximab combination","score":0.8740000128746033},{"id":"https://openalex.org/keywords/lymphoid-leukemia","display_name":"lymphoid leukemia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.939177393913269},{"id":"https://openalex.org/C2778867473","wikidata":"https://www.wikidata.org/wiki/Q17544382","display_name":"NKG2D","level":4,"score":0.8548685908317566},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.5310637950897217},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5209820866584778},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.48979759216308594},{"id":"https://openalex.org/C2779931124","wikidata":"https://www.wikidata.org/wiki/Q417823","display_name":"Fc receptor","level":3,"score":0.41665107011795044},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4096660912036896},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.38014620542526245},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36962923407554626},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35879725217819214},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3425934612751007},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2281172275543213},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07941755652427673},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06501564383506775}],"mesh":[{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055655","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily K","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055655","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily K","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/ijc.29083","doi":"https://doi.org/10.1002/ijc.29083","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ijc.29083","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:25046567","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25046567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/ijc.29083","doi":"https://doi.org/10.1002/ijc.29083","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ijc.29083","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1169940588","display_name":null,"funder_award_id":"109620","funder_id":"https://openalex.org/F4320323556","funder_display_name":"Deutsche Krebshilfe"},{"id":"https://openalex.org/G1560004781","display_name":null,"funder_award_id":"SFB 685","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G2349046182","display_name":null,"funder_award_id":"SA1360/7-1","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G3594111670","display_name":null,"funder_award_id":"2007.115.3","funder_id":"https://openalex.org/F4320310707","funder_display_name":"Wilhelm Sander-Stiftung"},{"id":"https://openalex.org/G7908448507","display_name":null,"funder_award_id":"SA1360/9\u20101","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"}],"funders":[{"id":"https://openalex.org/F4320310707","display_name":"Wilhelm Sander-Stiftung","ror":"https://ror.org/02q83sc19"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320323556","display_name":"Deutsche Krebshilfe","ror":"https://ror.org/01wxdd722"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W117604019","https://openalex.org/W1564461906","https://openalex.org/W1580335186","https://openalex.org/W1964265426","https://openalex.org/W1965543108","https://openalex.org/W1970264918","https://openalex.org/W1978667426","https://openalex.org/W1978755540","https://openalex.org/W1986134558","https://openalex.org/W1988264764","https://openalex.org/W2000269004","https://openalex.org/W2008402445","https://openalex.org/W2012501889","https://openalex.org/W2013473454","https://openalex.org/W2014349052","https://openalex.org/W2019278343","https://openalex.org/W2026462640","https://openalex.org/W2030614205","https://openalex.org/W2033107431","https://openalex.org/W2040935430","https://openalex.org/W2056563527","https://openalex.org/W2057745345","https://openalex.org/W2068335535","https://openalex.org/W2073300038","https://openalex.org/W2075901113","https://openalex.org/W2086121127","https://openalex.org/W2088052288","https://openalex.org/W2090912134","https://openalex.org/W2091229935","https://openalex.org/W2093762704","https://openalex.org/W2109440389","https://openalex.org/W2109502548","https://openalex.org/W2110500254","https://openalex.org/W2112574922","https://openalex.org/W2117269475","https://openalex.org/W2120372745","https://openalex.org/W2133205391","https://openalex.org/W2136385642","https://openalex.org/W2140516324","https://openalex.org/W2143330682","https://openalex.org/W2143562636","https://openalex.org/W2146313292","https://openalex.org/W2146494327","https://openalex.org/W2146783950","https://openalex.org/W2147068163","https://openalex.org/W2159115760","https://openalex.org/W2163123363","https://openalex.org/W2164204445","https://openalex.org/W2166521677","https://openalex.org/W2166970460","https://openalex.org/W6677679023"],"related_works":["https://openalex.org/W2584568853","https://openalex.org/W2728751605","https://openalex.org/W2090912134","https://openalex.org/W2555856381","https://openalex.org/W951397387","https://openalex.org/W2947632139","https://openalex.org/W2887769961","https://openalex.org/W2530913622","https://openalex.org/W2194342315","https://openalex.org/W3012490010"],"abstract_inverted_index":{"Recruitment":[0],"of":[1,19,29,37,55,59,118,152,168,192,207],"Fc-receptor-bearing":[2],"effector":[3],"cells,":[4,10],"such":[5],"as":[6,108,110],"natural":[7],"killer":[8],"(NK)":[9],"is":[11],"a":[12,79],"feature":[13],"critical":[14],"for":[15,61,205],"the":[16,27,38,56,98,165,189],"therapeutic":[17],"success":[18],"antitumor":[20],"antibodies":[21],"and":[22,87,93,114,199],"can":[23],"be":[24],"improved":[25],"by":[26,65,128,138],"modifications":[28],"an":[30,202],"antibody's":[31],"Fc":[32,73,81,101],"part.":[33],"The":[34],"various":[35],"ligands":[36],"activating":[39,193],"immunoreceptor":[40],"NKG2D,":[41],"NKG2DL)":[42],"are":[43],"selectively":[44],"expressed":[45],"on":[46],"malignant":[47,116],"cells":[48,64,113,117,178],"including":[49],"leukemia.":[50,161,208],"We":[51],"here":[52],"took":[53],"advantage":[54],"tumor-associated":[57,166],"expression":[58,167],"NKG2DL":[60,198],"targeting":[62],"leukemic":[63],"NKG2D-immunoglobulin":[66],"G":[67],"(IgG)1":[68],"fusion":[69],"proteins":[70],"containing":[71,78],"modified":[72],"parts.":[74],"Compared":[75],"to":[76,97,197],"NKG2D-Fc":[77],"wild-type":[80],"part":[82],"(NKG2D-Fc-WT),":[83],"our":[84],"mutants":[85],"(S239D/I332E":[86],"E233P/L234V/L235A/\u0394G236/A327G/A330S)":[88],"displayed":[89],"highly":[90],"enhanced":[91,135],"(NKG2D-Fc-ADCC)":[92],"abrogated":[94],"(NKG2D-Fc-KO)":[95],"affinity":[96],"NK":[99,112,126,171,185],"cell":[100,172],"receptor,":[102],"respectively.":[103],"Functional":[104],"analyses":[105],"with":[106,144,154,164],"allogenic":[107],"well":[109],"autologous":[111],"primary":[115],"leukemia":[119],"patients":[120],"revealed":[121],"that":[122],"NKG2D-Fc-KO":[123],"significantly":[124,147],"reduced":[125],"reactivity":[127,137,187],"blocking":[129],"immunostimulatory":[130],"NKG2D-NKG2DL":[131],"interaction.":[132],"NKG2D-Fc-WT":[133],"already":[134],"antileukemia":[136,186],"inducing":[139],"antibody-dependent":[140],"cellular":[141],"cytotoxicity":[142],"(ADCC)":[143],"NKG2D-Fc-ADCC":[145,153,182],"mediating":[146],"stronger":[148],"effects.":[149],"Parallel":[150],"application":[151],"Rituximab":[155],"caused":[156],"additive":[157],"effects":[158],"in":[159],"lymphoid":[160],"In":[162],"line":[163],"NKG2DL,":[169],"no":[170],"ADCC":[173],"against":[174],"resting":[175],"healthy":[176],"blood":[177],"was":[179],"induced.":[180],"Thus,":[181],"potently":[183],"enhances":[184],"despite":[188],"inevitable":[190],"reduction":[191],"signals":[194],"upon":[195],"binding":[196],"may":[200],"constitute":[201],"attractive":[203],"means":[204],"immunotherapy":[206]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}